Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
3
pubmed:dateCreated
2008-12-29
pubmed:abstractText
Mesenchymal stem cells (MSCs) have received special attention for cardiomyoplasty because several studies have shown that they differentiate into cardiomyocytes both in vitro and in vivo. Nitric oxide (NO) is a free radical signaling molecule that regulates several differentiation processes including cardiomyogenesis. Here, we report an investigation of the effects of two NO agents (SNAP and DEA/NO), able to activate both cGMP-dependent and -independent pathways, on the cardiomyogenic potential of bone marrow-derived mesenchymal stem cells (BM-MSCs) and adipose tissue-derived stem cells (ADSCs). The cells were isolated, cultured and treated with NO agents. Cardiac- and muscle-specific gene expression was analyzed by indirect immunofluorescence, flow cytometry, RT-PCR and real-time PCR. We found that untreated (control) ADSCs and BM-MSCs expressed some muscle markers and NO-derived intermediates induce an increased expression of some cardiac function genes in BM-MSCs and ADSCs. Moreover, NO agents considerably increased the pro-angiogenic potential mostly of BM-MSCs as determined by VEGF mRNA levels.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
1090-2104
pubmed:author
pubmed:issnType
Electronic
pubmed:day
16
pubmed:volume
378
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
456-61
pubmed:meshHeading
pubmed-meshheading:19032948-Adult, pubmed-meshheading:19032948-Adult Stem Cells, pubmed-meshheading:19032948-Aged, pubmed-meshheading:19032948-Antigens, CD, pubmed-meshheading:19032948-Cardiomyoplasty, pubmed-meshheading:19032948-Cell Differentiation, pubmed-meshheading:19032948-Cells, Cultured, pubmed-meshheading:19032948-Connexin 43, pubmed-meshheading:19032948-Gene Expression, pubmed-meshheading:19032948-Genetic Markers, pubmed-meshheading:19032948-Heart, pubmed-meshheading:19032948-Humans, pubmed-meshheading:19032948-Hydrazines, pubmed-meshheading:19032948-Mesenchymal Stem Cells, pubmed-meshheading:19032948-Middle Aged, pubmed-meshheading:19032948-Multipotent Stem Cells, pubmed-meshheading:19032948-Muscle Proteins, pubmed-meshheading:19032948-Myocytes, Cardiac, pubmed-meshheading:19032948-Nitric Oxide, pubmed-meshheading:19032948-Nitric Oxide Donors, pubmed-meshheading:19032948-Penicillamine, pubmed-meshheading:19032948-Vascular Endothelial Growth Factor A
pubmed:year
2009
pubmed:articleTitle
Expression of cardiac function genes in adult stem cells is increased by treatment with nitric oxide agents.
pubmed:affiliation
Núcleo de Cardiomioplastia Celular, Pontifícia Universidade Católica do Paraná, Rua Imaculada Conceição 1155, Curitiba 80215-901, Brazil.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't